Summary
Medulloblastoma is a malignant embryonal tumor predominantly of childhood. It occurs principally in the midline cerebellar region but is prone to invade the meninges and cerebrospinal fluid spaces. It is the principal posterior fossa tumor in children and represents 20% of all brain tumors in this age group. Considerable advances have been made in characterizing the morphologic subtypes, immunophenotypes, and in vitro behavior of cell lines. However, the cell of origin and its relationship to other related primitive neuroectodermal tumors remains uncertain. Although recent advances in the application of proliferation markers and the use of apoptosis in situ labelling have been applied, a prognostically relevant marker applicable to surgical neuropathology remains to be developed. The fundamental molecular pathogenesis of tumor development remains unknown, although recent exciting advances have shown alterations in some members of the PAX family of genes as well as increased expression of neurotrophin receptors. These may prove to be of prognostic significance.
Similar content being viewed by others
References
Friedman HS, Oakes WJ, Bigner SH, Wikstrand CJ, Bigner DD: Medulloblastoma: tumor biological and clinical perspectives. J Neuro-Oncol 11: 1–15, 1991
Walker RW Rosenblum MK: Childhood medulloblastoma. Rev Neurol (Paris) 148: 467–476, 1992
Tomlinson FH, Scheithauer BW, Meyer FB, Smithson WA, Shaw EG, Miller GM, Groover RV: Medulloblastoma: I. Clinical, diagnostic, and therapeutic overview. J Child Neurol 7: 142–155. 1992
Tomlinson FH, Scheithauer BW Jenkins RB: Medulloblastoma: II. A pathobiologic overview. J Child Neurol 7: 240–252, 1992
Katsetos CD, Burger PC: Medulloblastoma. In: Seminars in Diagnostic Pathology 11: 85–97, 1994
Trojanowski JQ, Fung K-M, Rorke LB, Tohyama T, Yachnis AT, Lee VM-Y: In vivo and in vitro models of medulloblastomas and other primitive neuroectodermal brain tumors of childhood. Mot Chem Neuropathol 21: 219–239, 1994
Kalino H, Palärvi L, Ekfors T Pellinierni LJ: Pigmented primitive neuroectodermal tumor with multipotential differentiation in cerebellum (pigmented medullomyoblastoma): A case of light- and electron-microscopic, and immunohistochemical analysis. Pediatr Neurosci 13: 188–195, 1987
Giangaspero F, Rigobello L, Badiali M, Loda M, Andreini L, Basso G, Zorzi F, Montaldi A: Large cell medulloblastoma. A distinct variant with aggressive behaviour. Am J Surg Pathol 16: 687–693, 1992
Trojanowski JQ, Tohyama T, Lee VM-Y: Medulloblastomas and related primitive neuroectodermal brain tumors of childhood recapitulate molecular milestones in the maturation of neuroblasts. Mol Chem Neuropathol 17: 121–135, 1992
Provias J, Becker LE: CD-44 expression in brain tumors. An immunohistochemical and scanning electron microscopic study emphasizing astrocytomas (Abstract). Brain Pathol 4: 410, 1994
Maraziotis T, Perentes E, Karamitopoulou E, Nakagawa Y, Gessaga EC, Probst A, Frankfurter A: Neuron-associated class III ß-tubulin isotype, retinal S-antigen, synaptophysin, and glial fibrillary acidic protein in human medulloblastomas: a clinicopathological analysis of 36 cases. Acta Neuropathol (Berl) 84: 355–363, 1992
Segal RA, Goumnerov LC, Kwon YK, Stiles CD, Pomeroy SL: Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci USA 91: 12867–12871, 1994
Malkin D, Li FP, Strong LC, Fraumeni JG, Nelson C, Kim DH, Kassel J, Gryka MA, Bishoff FZ, Taisky MA, Friend SH: Germline p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1222–1228, 1990
Louis DN, von Deimling A: Hereditary tumor syndromes of the nervous system: Overview and rare syndromes. Brain Pathol 5: 145–151, 1995
Evans DGR, Farndon PA, Burnell LD, Gattamaneni R, Birch JM: The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer 64: 959–961, 1991
Rainov NG, Lübbe J, Renshaw J, Pritchard-Jones K, Lüthy AR, Aguzzi A: Association of Wilms' tumor with primary brain tumor in siblings. J Neuropathol Exp Neurol 54: 214–223, 1995
Frost G, Patel K, Bourne S, Coakham HB, Kemshead JT: Expression of alternative isoforms of the neural cell adhesion molecule (NCAM) on normal brain and variety of brain tumours. Neuropathol Appl Neurobiol 17: 207–217, 1991
Tohyama T, Lee VM-Y, Rorke LB, Marvin M, McKay RDG, Trojanowski JQ: Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. Lab Invest 66: 303–313, 1992
Schiffer D, Cavalla P, Chiò A, Giordana MT, Marino S, Mauro A, Migheli A: Tumor cell proliferation and apoptosis in medulloblastoma. Acta Neuropathol (Berl) 87: 362–370, 1994
Jay V Parkinson D, Becker L, Chan F-W: Cell kinetic analysis in pediatric brain and spinal tumors: A study of 117 cases with Ki-67 quantitation and flow cytometry. Pediatr Pathol 14: 253–276, 1994
Wyllie AH: Apoptosis (The 1992 Frank Rose Memorial Lecture). Br J Cancer 67: 205–208, 1993
Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1–6, 1994
Heck K, Pyle P, Bruner JH: Bcl-2 expression in cerebellar medulloblastomas (Abstract). Brain Pathol 4: 438, 1994
Meyer JS, Marchosky A, Hickey WF: Cell kinetic classification of tumors of the nervous system by DNA precursor labeling in vitro. Hum Pathol 24: 1357–1364, 1993
Yasue M, Tomita T, Engelhard H, Gonzalez-Crussi F, McLone DG, Bauer KD: Prognostic importance of DNA ploidy in medulloblastoma of childhood. J Neurosurg 70: 385–391, 1989
Bigner SH, Mark J, Friedman HS, Biegel JA, Bigner DD: Structural chromosomal abnormalities in human medulloblastoma. Cancer Genet Cytogenet 30: 91–101, 1988
Griffin CA, Hawkins AL, Packer RJ, Rorke LB, Emanuel BS: Chromosome abnormalities in pediatric brain tumors. Cancer Res 48: 175–180, 1988
Raffel C, Gilles FE, Weinberg KI: Reduction to homozygosity and gene amplification in central nervous system primitive neuroectodermal tumors of childhood. Cancer Res 50: 587–591, 1990
Raffel C, Thomas GA, Tishler DM, Lassoff S, Allen JC: Absence of p53 mutations in childhood central nervous system primitive neuroectodermal tumors. Neurosurgery 33: 301–306, 1993
Louis DN: The p53 gene and protein in human brain tumors. J Neuropathol Exp Neurol 53: 11–21, 1994
Jay V, Pienkowska M, Becker L, Zielenska M: Primitive neuroectodermal tumors of the cerebrum and cerebellum: Absence of t(11,22) translocation by RT-PCR analysis. Mod Pathol 8: 488–491, 1995
Jay V, Lorenzana A, Drake K, Zielenska M: An unusual cerebellar primitive neuroectodermal tumor with t(11,22) translocation: Pathological and molecular analysis. Pediatr Pathol (In press)
Weinberg R: Tumor suppressor genes. Neuron 11: 191–196, 1993
Wasson JC, Saylors III RL, Zeltzer P, Friedman HS, Bigner SH, Burger PC, Bigner DD, Look AT, Douglass EC, Brodeur GM: Oncogene amplification in pediatric brain tumors. Cancer Res 50: 2987–2990, 1990
Bandiali M, Pession A, Basso G, Andreini L, Rigobello L, Galassi E, Giangaspero F: N-myc and C-myc oncogenes amplification in medulloblastomas. Evidence of particularly aggressive behavior of a tumor with C-myc amplification. Tumori 77: 118–121, 1991
Jay V, Squire J, Zielenska M, Gerrie B, Humphreys R: Molecular and cytogenetic analysis of a cerebellar primitive neuroectodermal tumor with prominent neuronal differentiation: Detection of MYCN amplification by differential polymerase chain reaction and Southern blot analysis. Pediatr Pathol (In press)
Tomlinson FH, Jenkins RB, Scheithauer BW, Keelan PA, Ritland S, Parisi JE, Cunningham J, Olsen KD: Aggressive medulloblastoma with high-level N-myc amplification. Mayo Clin Proc 69: 359–365, 1994
Rouah E, Wilson DR, Armstrong DL, Darlington GJ: N-myc amplification and neuronal differentiation in human primitive neuroectodermal tumors of the central nervous system. Cancer Res 49: 1797–1801, 1989
Guha A: Platelet-derived growth factor: A general review with emphasis on astrocytomas. Pediatr Neurosurg 17: 14–20, 1991–1992
Plate KH, Breier G, Risau W: Molecular mechanisms of development and tumor angiogenesis. Brain Pathol 4: 207–218, 1994
Berkman RA, Merill MJ, Reinhold WC, Monacci WT, Saxena A, Clark WC, Robertson JT, Ali IU, Oldfield EH: Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 91: 152–159, 1993
Kozmik Z, Sure U, Rüedi D, Busslinger M, Aguzzi A: Deregulated expression of PAX5 in medulloblastoma. Proc Natl Acad Sci USA 92: 5709–5713, 1995
Fung K-M, Trojanowski JQ: Animal models of medulloblastomas and related primitive neuroectodermal tumors. A review. J Neuropathol Exp Neurol 54: 285–296, 1995
He X, Wikstrand CJ, Friedman HS, Bigner SH, Pleasure S, Trojanowski JQ, Bigner DD: Differentiation characteristics of newly established medulloblastoma cell lines (D384 Med, D425 Med, and D458 Med) and their transplantable xenografts. Lab Invest 64: 833–843, 1991
Friedman HS, Burger PC, Bigner SH, Trojanowski JQ, Brodeur GM, He X, Wikstrand CJ, Kurtzberg J, Berens ME, Halperin EC, Bigner DD: Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc. Am J Pathol 130: 472–484, 1988
Pietsch T, Scharmann T, Fonatsch C, Schmidt D, Ockler R, Freihoff D, Albrecht A, Wiestler OD, Zeltzer P, Riehm H: Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system. Cancer Res 54: 3278–3287, 1994
Eibl RH, Kleihues P, Jat PS, Wiestler PD: A model for primitive neuroectodermal tumors in transgenic neural transplants harboring the SV40large T antigen. Am J Pathol 144: 556–565, 1994
Fung K-M, Chikaraishi DM, Suri C, Theuring F, Messing A, Albert DM, Lee VM-L, Trojanowski JQ: Molecular phenotype of Simian virus 40 large T antigen-induced primitive neuroectodermal tumors in four different lines of transgenic mice. Lab Invest 70: 114–124, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Provias, J.P., Becker, L.E. Cellular and molecular pathology of medulloblastoma. J Neuro-Oncol 29, 35–43 (1996). https://doi.org/10.1007/BF00165516
Issue Date:
DOI: https://doi.org/10.1007/BF00165516